New York State Common Retirement Fund’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-192
| Closed | – | – | 3353 |
|
2023
Q2 | $0 | Sell |
192
-11,958
| -98% | – | ﹤0.01% | 3406 |
|
2023
Q1 | $27K | Sell |
12,150
-209
| -2% | -$464 | ﹤0.01% | 3086 |
|
2022
Q4 | $43K | Sell |
12,359
-21,237
| -63% | -$73.9K | ﹤0.01% | 3112 |
|
2022
Q3 | $1.24M | Buy |
33,596
+13,415
| +66% | +$497K | ﹤0.01% | 1866 |
|
2022
Q2 | $383K | Buy |
20,181
+7,137
| +55% | +$135K | ﹤0.01% | 2480 |
|
2022
Q1 | $352K | Hold |
13,044
| – | – | ﹤0.01% | 2563 |
|
2021
Q4 | $294K | Sell |
13,044
-9
| -0.1% | -$203 | ﹤0.01% | 2721 |
|
2021
Q3 | $342K | Buy |
13,053
+39
| +0.3% | +$1.02K | ﹤0.01% | 2669 |
|
2021
Q2 | $417K | Buy |
13,014
+114
| +0.9% | +$3.65K | ﹤0.01% | 2699 |
|
2021
Q1 | $454K | Hold |
12,900
| – | – | ﹤0.01% | 2501 |
|
2020
Q4 | $414K | Hold |
12,900
| – | – | ﹤0.01% | 2437 |
|
2020
Q3 | $485K | Hold |
12,900
| – | – | ﹤0.01% | 2227 |
|
2020
Q2 | $577K | Buy |
+12,900
| New | +$577K | ﹤0.01% | 2135 |
|